Protocol core biopsy (CADI): a surrogate marker for chronic rejection. Mycophenolate Mofetil ICM 1866 and IICR 023 Study Groups

Transplant Proc. 2000 Feb;32(1A Suppl):12S. doi: 10.1016/s0041-1345(00)00809-5.
No abstract available

MeSH terms

  • Biopsy
  • Chronic Disease
  • Follow-Up Studies
  • Graft Rejection / pathology*
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / immunology
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology
  • Kidney Transplantation / pathology*
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use
  • Regression Analysis
  • Risk Factors
  • Time Factors
  • Transplantation, Homologous / pathology

Substances

  • Immunosuppressive Agents
  • Mycophenolic Acid